Changes in the coagulation parameters in dogs with protein-losing enteropathy between before and after treatment

• Published in: Journal of Veterinary Medical Science Vol. 83; no. 8; pp. 1295 - 1302
• Main Authors: NAGAHARA, Takuro, OHNO, Koichi, NAGAO, Itsuma, NAKAGAWA, Taisuke, YOKOYAMA, Nozomu, OHMI, Aki, GOTO-KOSHINO, Yuko, CHAMBERS, James K., UCHIDA, Kazuyuki, TOMIYASU, Hirotaka, TSUJIMOTO, Hajime
• Format: Journal Article
• Language: English
• Published: Tokyo JAPANESE SOCIETY OF VETERINARY SCIENCE 2021; Japan Science and Technology Agency; The Japanese Society of Veterinary Science
• Subjects: Antithrombin; Clotting; Coagulation; dog; Fibrinogen; Fibrinolysis; Internal Medicine; Lysis; protein-losing enteropathy; Prothrombin; Remission; Thrombin; Thromboembolism; Thromboplastin; treatment
• ISSN: 0916-7250; 1347-7439
• DOI: 10.1292/jvms.21-0137

Protein-losing enteropathy (PLE) is known to induce hypercoagulability and resultant thromboembolism in dogs. We hypothesized that hypercoagulability would improve if remission was obtained in dogs with PLE after treatment. This study aimed to evaluate the changes in the coagulation parameters after treatment in dogs diagnosed with PLE. As coagulation parameters, prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen, thrombin-antithrombin complex (TAT), D-dimer, and antithrombin (AT) were measured. In addition to these parameters, rotational thromboelastometry (ROTEM), which evaluates the comprehensive coagulation and fibrinolysis reactions of whole blood, was conducted and the data of clotting time (CT), clot formation time (CFT), α angle (α), maximum clot firmness (MCF) and lysis index at 60 min (LI60) were obtained. Eleven of the 14 dogs diagnosed with PLE were classified as responders to the treatment based on the changes in their plasma albumin (ALB) concentration after treatment. Significant increase in CFT and decrease of α and MCF indicating the resolution of hypercoagulability were found after treatment in responder dogs; however, there was no significant change in the coagulation and fibrinolysis parameters other than those measured by ROTEM. This study demonstrated that the hypercoagulability detected by ROTEM was significantly improved after treatment in dogs with PLE.